Cargando…

Extra energy for hearts with a genetic defect: ENERGY trial

AIMS: Previous studies have shown that hypertrophic cardiomyopathy mutation carriers have a decreased myocardial energy efficiency, which is thought to play a key role in the pathomechanism of hypertrophic cardiomyopathy (HCM). The ENERGY trial aims to determine whether metabolic drugs correct decre...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Driel, B. O., van Rossum, A. C., Michels, M., Huurman, R., van der Velden, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2019
Materias:	Original Article – Design Study Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439046/ https://www.ncbi.nlm.nih.gov/pubmed/30767167 http://dx.doi.org/10.1007/s12471-019-1239-0

Ejemplares similares

Correction to: Extra energy for hearts with a genetic defect: ENERGY trial
por: van Driel, B. O., et al.
Publicado: (2019)

Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial
por: ter Maaten, Jozine M., et al.
Publicado: (2022)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
por: Scheffer, Mariëlle, et al.
Publicado: (2020)

Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2018)

Regional management of worsening heart failure: rationale and design of the CHAIN‐HF registry
por: Shakoor, Abdul, et al.
Publicado: (2023)

Data based investigation of the energy metering type, billing and usage of sampled residents of Ota Community in Nigeria
por: Adekitan, Aderibigbe Israel, et al.
Publicado: (2018)

Data on energy and economic evaluation and microbial assessment of anaerobic co-digestion of fruit rind of Telfairia occidentalis (Fluted pumpkin) and poultry manure
por: Dahunsi, S.O., et al.
Publicado: (2018)

Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial
por: Zannad, Faiez, et al.
Publicado: (2015)

Effect of melatonin on heart failure: design for a double‐blinded randomized clinical trial
por: Sadeghi, Masoumeh, et al.
Publicado: (2020)

Heart failure and promotion of physical activity before and after cardiac rehabilitation (HF‐aPProACH): a study protocol
por: Limpens, Marlou A.M., et al.
Publicado: (2021)

Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
por: Hundertmark, Moritz J., et al.
Publicado: (2021)

Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE‐HF) trial
por: Keene, Daniel, et al.
Publicado: (2018)

Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study
por: Zelenak, Christine, et al.
Publicado: (2023)

Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT‐AHF trial
por: Su, Yang, et al.
Publicado: (2020)

PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France
por: Duflos, Claire, et al.
Publicado: (2020)

Design of the Prospective Comparison of Angiotensin Receptor-Neprilysin Inhibitor Versus Placebo in Patients With Congenital Systemic Right Ventricle Heart Failure (PARACYS-RV) Trial
por: Chaix, Marie-A., et al.
Publicado: (2023)

Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA‐ADHF‐DZHK10 trial
por: Jobs, Alexander, et al.
Publicado: (2020)

Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure
por: Packer, Milton, et al.
Publicado: (2020)

Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial
por: Tromp, Jasper, et al.
Publicado: (2021)

The genomics of heart failure: design and rationale of the HERMES consortium
por: Lumbers, R. Thomas, et al.
Publicado: (2021)

The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study
por: Ekström, Mattias, et al.
Publicado: (2020)

Catheter ablation for atrial fibrillation in patients with end‐stage heart failure and eligibility for heart transplantation
por: Sohns, Christian, et al.
Publicado: (2020)

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
por: McMurray, John J. V., et al.
Publicado: (2013)

Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
por: Dauw, Jeroen, et al.
Publicado: (2021)

BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status
por: Jansen, M., et al.
Publicado: (2021)

PRecision Event Monitoring for PatienTs with Heart Failure using HeartLogic (PREEMPT‐HF) study design and enrolment
por: Boehmer, John, et al.
Publicado: (2023)

Impact of B‐lines‐guided intensive heart failure management on outcome of discharged heart failure patients with residual B‐lines
por: Zhu, Yunlong, et al.
Publicado: (2022)

Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: the rationale, design and methodology of the HF‐Wii study; a multicentre randomized controlled trial
por: Jaarsma, Tiny, et al.
Publicado: (2015)

Kyoto Congestive Heart Failure (KCHF) study: rationale and design
por: Yamamoto, Erika, et al.
Publicado: (2017)

The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network
por: Davies, Brianna, et al.
Publicado: (2020)

A Randomized Controlled Trial Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation in the General Population: E3 Trial Design
por: Hébert-Losier, Andréa, et al.
Publicado: (2020)

Heart failure prevalence in the general population: SOBOTA‐HF study rationale and design
por: Lainscak, Mitja, et al.
Publicado: (2019)

Activity Sensors to Evaluate the Effect of Sacubitril/Valsartan on Quality‐of‐Life in Heart Failure: rational and design of the AWAKE‐HF study
por: Khandwalla, Raj M., et al.
Publicado: (2019)

Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry
por: Zeymer, Uwe, et al.
Publicado: (2020)

Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA‐R)
por: Sinning, Christoph, et al.
Publicado: (2021)

Design of a multifaceted strategy based on automated text messaging in patients with recent heart failure admission
por: Rohde, Luis E., et al.
Publicado: (2021)

Utilizing longitudinal data in assessing all‐cause mortality in patients hospitalized with heart failure
por: Herman, Robert, et al.
Publicado: (2022)

Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR‐AHF
por: Palazzuoli, Alberto, et al.
Publicado: (2017)

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period
por: Pölzl, Gerhard, et al.
Publicado: (2018)

Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS)
por: Yun, Sergi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_21q31i0u5tn466gtnc128ofcpc